WBA vs. GSK
WBA (Walgreens Boots Alliance, Inc.) and GSK (GlaxoSmithKline plc) are both stocks. Both are in the Healthcare sector — WBA in Pharmaceutical Retailers, GSK in Drug Manufacturers - General. At a 0.26 correlation, their price movements are largely independent.
Performance
WBA vs. GSK - Performance Comparison
Loading charts...
Returns By Period
WBA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GSK
- 1D
- -0.63%
- 1M
- -4.31%
- YTD
- 1.52%
- 6M
- 3.13%
- 1Y
- 21.87%
- 3Y*
- 17.32%
- 5Y*
- 4.44%
- 10Y*
- 3.81%
WBA vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
WBA Walgreens Boots Alliance, Inc. | 0.00% | 28.40% | -61.34% | -25.09% | -25.06% | 35.78% | -29.38% | -10.99% | -3.65% | -10.51% |
GSK GlaxoSmithKline plc | 1.52% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
Correlation
The correlation between WBA and GSK is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jul 10, 1986 | 0.26 |
The correlation between WBA and GSK shifts across timeframes, from 0.08 (1 year) to 0.26 (all time), reflecting how their relationship changes across market environments.
Fundamentals
WBA:
$154.58B
GSK:
$32.78B
WBA:
$26.47B
GSK:
$23.87B
WBA:
-$2.92B
GSK:
$11.30B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WBA vs. GSK — Risk / Return Rank
WBA
GSK
WBA vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Walgreens Boots Alliance, Inc. (WBA) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| WBA | GSK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.82 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.18 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.17 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | 0.32 | — |
Drawdowns
WBA vs. GSK - Drawdown Comparison
Loading charts...
Drawdown Indicators
| WBA | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -55.70% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -18.63% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -28.46% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -50.10% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -50.10% | — |
Current DrawdownCurrent decline from peak | — | -18.63% | — |
Average DrawdownAverage peak-to-trough decline | — | -18.87% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 7.87% | — |
Volatility
WBA vs. GSK - Volatility Comparison
Loading charts...
Volatility by Period
| WBA | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.30% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 18.38% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 26.85% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 25.01% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 22.86% | — |
Dividends
WBA vs. GSK - Dividend Comparison
WBA has not paid dividends to shareholders, while GSK's dividend yield for the trailing twelve months is around 3.53%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 3.53% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
WBA Walgreens Boots Alliance, Inc. | 0.00% | 0.00% | 10.72% | 7.35% | 5.13% | 3.62% | 4.64% | 3.04% | 2.46% | 2.13% | 1.78% | 1.64% |
Financials
WBA vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Walgreens Boots Alliance, Inc. and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
WBA and GSK have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for WBA and GSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer